marijuana stocks

PharmaCyte Biotech, Inc. (PMCB)

 
Income Statement Get Income Statement for:
View: Annual Data | Quarterly Data All numbers in thousands
Period Ending Jan 31, 2015 Oct 31, 2014 Jul 31, 2014 Apr 30, 2014
Total Revenue –   –   –   –  
Cost of Revenue
Gross Profit –   –   –   –  
Operating Expenses
Research Development 274 348
Selling General and Administrative 946 5,544 1,322 15,202
Non Recurring 236 353 261 1,247
Others
Total Operating Expenses
Operating Income or Loss (1,457) (6,245) (1,583) (16,449)
Income from Continuing Operations
Total Other Income/Expenses Net 0 2,184 1 (19)
Earnings Before Interest And Taxes (1,457) (4,062) (1,582) (12,474)
Interest Expense 2 2 3 3
Income Before Tax (1,458) (4,064) (1,585) (12,478)
Income Tax Expense
Minority Interest
Net Income From Continuing Ops (1,458) (4,064) (1,585) (16,471)
Non-recurring Events
Discontinued Operations
Extraordinary Items
Effect Of Accounting Changes
Other Items
Net Income (1,458) (4,064) (1,585) (16,471)
Preferred Stock And Other Adjustments
Net Income Applicable To Common Shares (1,458) (4,064) (1,585) (16,471)

MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Integrated Cannabis Company, Inc. (ICNAF) (ICAN)Provides Corporate Update

Highlights Ganja Gold products now in 275 dispensaries across California; Proprietary pre-roll…

AbbVie Inc. (ABBV) Cariprazine (VRAYLAR®) Met Primary Endpoint in Phase 3 Study

AbbVie’s Cariprazine (VRAYLAR®) Met Primary Endpoint in Phase 3 Study as an…

High Tide Inc. (HITI) to Acquire Bud Heaven, Adding Two Established Retail Cannabis Stores in Ontario

High Tide to Acquire Bud Heaven, Adding Two Established Retail Cannabis Stores…